India seeks US intervention in Ranbaxy fraud trial
This article was originally published in Scrip
Executive Summary
India is seeking the intervention of the US government in theRanbaxy case, where the company is being investigated for submitting allegedly fabricated data for its generics to theFDA, among other charges.